Treatment of chronic HBeAg-positive hepatitis with acyclovir: A controlled trial

This publication has 11 references indexed in Scilit:

• Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2′-deoxy-2′-fluoro-β-d-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2′-deoxyuridine
  Antiviral Research, 1984
• Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication
  Liver International, 1984
• Acyclovir in hepatitis B antigen—positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration
  Journal of Antimicrobial Chemotherapy, 1983
• Spontaneous Disappearance of Viral Replication and Liver Cell Inflammation in Hbsag–Positive Chronic Active Hepatitis: Results of A Placebo Vs. Interferon Trial
  Hepatology, 1982
• Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
  Gut, 1982
• Preliminary studies of acyclovir in chronic hepatitis B
  The American Journal of Medicine, 1982
• Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination
  Antimicrobial Agents and Chemotherapy, 1982
• Effect of Liver Disease on Pharmacokinetics and Toxicity of 9- -D-Arabinofuranosyladenine-5'-Phosphate
  The Journal of Infectious Diseases, 1981
• Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside
  The Journal of Infectious Diseases, 1981
• Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis
  Annals of Internal Medicine, 1981